Xarelto (Rivaroxaban) is an anti-coagulant or blood-thinning drug that is used to prevent harmful blood clots in patients who have undergone hip replacement surgery or have suffered from stroke or heart attack. By thinning the blood and counteracting its natural clotting mechanisms, anticoagulants ensure that blood will continue to circulate through the organs. Blood thinners play a vital role in the health of millions of U.S, patients and represent a huge share of the pharmaceutical market, estimated over $10 billion. Xarelto is a relatively new blood thinner whose unique health risks are resulting in Xarelto bleeding lawsuits.
Coumadin has long been the standby blood thinner of choice in the United States. While effective, the drug requires patients to adjust their diets and report for frequent checkups to adjust dosage levels. Xarelto and other oral anticoagulants have become popular because they are far more convenient for patients. However, when the drugs were fast-tracked through the FDA approval process, the risks associated with Xarelto were not fully researched. Today, adverse event reports show that patients taking Xarelto are at risk of severe bleeding incidents. Unlike Coumadin, Xarelto has no known antidote - meaning that once hemorrhaging or internal bleeding begins, there is no reliable way to stop the blood thinning effects of the drug in order to stop the bleeding. Patients taking Xarelto can therefore suffer from and even die as a result of severe bleeding events.
A study published in the New England Journal of Medicine in 2011 showed that Xarelto is no more effective than Coumadin. Without a proven antidote, Xarelto is substantially more dangerous than its alternatives. The producers of Xarelto received an FDA warning letter in 2013 for their failure to adequately warn patients of the bleeding risk.
The manufacturers of Xarelto, Bayer and Janssen Pharmaceuticals, failed to inform consumers of the potentially life threatening risks associated with the drug, and still have not provided medical professionals with information on how to halt dangerous Xarelto bleeding. By putting profits before research and safety, the makers of Xarelto have endangered and harmed countless Americans.
Individuals and the family members of persons who experienced severe bleeding incidents while taking Xarelto may be entitled to real compensation through a Xarelto bleeding lawsuit. Our attorneys provide free Xarelto claim reviews, and will be happy to answer your questions and help you to understand your legal options. All Xarelto bleeding lawsuit services are provided on a contingency basis, meaning there are no legal fees unless we win compensation on your behalf.
Filing a lawsuit is the best means for individual consumers to hold pharmaceutical companies accountable for harmful products. By placing profit motives ahead of consumer safety, the makers of Xarelto have caused undue harm and loss to Americans and their families while lining their own pockets. Negligent and unscrupulous pharmaceutical companies canâ€”and shouldâ€”be held accountable for their actions, and injured consumers have a right to seek justice. Filing a Xarelto lawsuit enables consumers to hold the companies accountable for the safety of their products.
The Onder Law Firm has a national reputation for its work in family and consumer safety based on an ethic of hard work, reliable advice, and achieving results on behalf of our clients. We will work tirelessly to ensure each of our clients has trustworthy and excellent legal representation. Contact our attorneys to ensure you have an experienced advocate fighting on behalf of your family.
To speak with a lawyer handling Xarelto bleeding claims, contact our firm today. For more information, please visit our Xarelto Internal Bleeding Lawsuit website.
Scott G Williams MD, FACOG
Dr Williams is a board certified obstetrician/gynecologist who serves as chief medical consultant for Onder Law. During more than 20 years as a practicing ob/gyn in St Charles county, Dr Williams delivered thousands of babies, performed surgery on a daily basis, and was considered one of the top providers in his profession. He served as chief of ob/gyn at two of the three hospitals in St Charles county, and currently is the full time medical director of St Louis area obstetric hospitalist program.
In addition, Dr Williams has served as a long time consultant in medical and pharmaceutical litigation for Onder Law. With a background that includes scientific research as well as medical practice, Dr Williams is adept at interpreting pharmaceutical and medical device studies. His past analyses have included research on the harmful effects of contraceptive devices, talc/ ovarian cancer and the blood clotting effects of certain oral contraceptives.
Clients would not commonly meet with Dr Williams as he is not an attorney, but his expertise forms an important part of Onder Law's client strategies for medical and pharmaceutical products. Dr Williams is often a crucial "behind the scenes" part of formulating a winning approach for your case.
Scott G Williams, MD, FACOG, is a 1986 graduate of the University of Notre Dame. His MD was earned at the University of Missouri Columbia and he completed residency at the well regarded University of Florida-Gainesville Ob/Gyn program. Dr Williams and his wife (who is also a physician) live with two labrador retrievers; their son and daughter are at college.